“Antibody response to breakthrough SARS-CoV-2 infection in ‘booster’ vaccinated patients with multiple myeloma according to B/T/NK lymphocyte absolute counts and anti-CD38 treatments”, Mediterr J Hematol Infect Dis, vol. 16, no. 1, p. e2024022, Feb. 2024, doi: 10.4084/MJHID.2024.022.